206 related articles for article (PubMed ID: 36340711)
1. Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: A single-center experience.
Szczawińska-Popłonyk A; Tąpolska-Jóźwiak K; Schwartzmann E; Pietrucha B
Front Pediatr; 2022; 10():972952. PubMed ID: 36340711
[TBL] [Abstract][Full Text] [Related]
2. Effect of Class Switch Recombination Defect on the Phenotype of Ataxia-Telangiectasia Patients.
Amirifar P; Mozdarani H; Yazdani R; Kiaei F; Moeini Shad T; Shahkarami S; Abolhassani H; Delavari S; Sohani M; Rezaei A; Hassanpour G; Akrami SM; Aghamohammadi A
Immunol Invest; 2021 Feb; 50(2-3):201-215. PubMed ID: 32116070
[No Abstract] [Full Text] [Related]
3. The clinical significance of complete class switching defect in Ataxia telangiectasia patients.
Ghiasy S; Parvaneh L; Azizi G; Sadri G; Zaki Dizaji M; Abolhassani H; Aghamohammadi A
Expert Rev Clin Immunol; 2017 May; 13(5):499-505. PubMed ID: 28162005
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
[TBL] [Abstract][Full Text] [Related]
5. Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM.
Mohammadinejad P; Abolhassani H; Aghamohammadi A; Pourhamdi S; Ghosh S; Sadeghi B; Nasiri Kalmarzi R; Durandy A; Borkhardt A
J Immunoassay Immunochem; 2015; 36(1):16-26. PubMed ID: 24568663
[TBL] [Abstract][Full Text] [Related]
6. Granulomatous Liver Disease in Ataxia-Telangiectasia With the Hyper-IgM Phenotype: A Case Report.
Szczawińska-Popłonyk A; Ossowska L; Jończyk-Potoczna K
Front Pediatr; 2020; 8():570330. PubMed ID: 33330270
[TBL] [Abstract][Full Text] [Related]
7. Vasculitis in a Child With the Hyper-IgM Variant of Ataxia-Telangiectasia.
Meyer AK; Banks M; Nadasdy T; Clark JJ; Zheng R; Gelfand EW; Abbott JK
Front Pediatr; 2019; 7():390. PubMed ID: 31709200
[TBL] [Abstract][Full Text] [Related]
8. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.
Jhamnani RD; Nunes-Santos CJ; Bergerson J; Rosenzweig SD
Front Immunol; 2018; 9():2172. PubMed ID: 30319630
[TBL] [Abstract][Full Text] [Related]
9. Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome.
Aghamohammadi A; Imai K; Moazzami K; Abolhassani H; Tabatabaeiyan M; Parvaneh N; Nasiri Kalmarzi R; Nakagawa N; Oshima K; Ohara O; Nonoyama S; Rezaei N
J Investig Allergol Clin Immunol; 2010; 20(5):442-5. PubMed ID: 20945614
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of IgM against colonization of the respiratory tract by nontypeable Haemophilus influenzae in patients with hypogammaglobulinemia.
Micol R; Kayal S; Mahlaoui N; Beauté J; Brosselin P; Dudoit Y; Obenga G; Barlogis V; Aladjidi N; Kebaili K; Thomas C; Dulieu F; Monpoux F; Nové-Josserand R; Pellier I; Lambotte O; Salmon A; Masseau A; Galanaud P; Oksenhendler E; Tabone MD; Teira P; Coignard-Biehler H; Lanternier F; Join-Lambert O; Mouillot G; Theodorou I; Lecron JC; Alyanakian MA; Picard C; Blanche S; Hermine O; Suarez F; Debré M; Lecuit M; Lortholary O; Durandy A; Fischer A
J Allergy Clin Immunol; 2012 Mar; 129(3):770-7. PubMed ID: 22153772
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity in hyper-IgM syndrome.
Jesus AA; Duarte AJ; Oliveira JB
J Clin Immunol; 2008 May; 28 Suppl 1():S62-6. PubMed ID: 18246414
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan.
Morio T; Takahashi N; Watanabe F; Honda F; Sato M; Takagi M; Imadome KI; Miyawaki T; Delia D; Nakamura K; Gatti RA; Mizutani S
Int J Hematol; 2009 Nov; 90(4):455-462. PubMed ID: 19705055
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
14. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
15. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
[TBL] [Abstract][Full Text] [Related]
16. The hyper IgM syndrome--an evolving story.
Etzioni A; Ochs HD
Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Radiation Sensitivity in Patients with Hyper IgM Syndrome.
Fekrvand S; Mozdarani H; Delavari S; Sohani M; Nazari F; Kiaee F; Bagheri Y; Azizi G; Hassanpour G; Mozdarani S; Abolhassani H; Aghamohammadi A; Yazdani R
Immunol Invest; 2021 Jul; 50(5):580-596. PubMed ID: 32584193
[TBL] [Abstract][Full Text] [Related]
18. Clinical Phenotypes of Hyper-IgM Syndromes.
de la Morena MT
J Allergy Clin Immunol Pract; 2016; 4(6):1023-1036. PubMed ID: 27836054
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous and systemic granulomatosis in ataxia-telangiectasia: a clinico-pathological study.
Szczawińska-Popłonyk A; Olejniczak K; Tąpolska-Jóźwiak K; Boruczkowski M; Jończyk-Potoczna K; Małdyk J; Bręborowicz A
Postepy Dermatol Alergol; 2020 Oct; 37(5):760-765. PubMed ID: 33240017
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
